- This event has passed.
WEBINAR: Infection Control: Prevention
April 3 @ 11:00 am - 12:00 pm
We are pleased to have presented this segment of our no-cost educational program series for Long Term Care Facilities entitled: Navigating Infection Control and Antimicrobial Stewardship in Long-Term Care. Hosted by the New England QIN-QIO in partnership with the Massachusetts Department of Public Health (MDPH), this virtual series features presentations from Shira Doron, MD, Kirthana Beaulac, PharmD, and Gabriela Andujar Vazquez, MD, Antimicrobial Stewardship specialists at Tufts Medical Center.
We hope you were able to participate in the fourth session, Infection Control: Prevention, on Tuesday, April 3 from 11:00am to 12:00pm.
By attending this webinar, participants were able to:
- Discuss the elements that are essential to an infection control policy
- Outline the key strategies for prevention of device associated infections
- Review the special steps required to prevent the spread of highly resistant bacteria
More About our Speakers
Shira Doron, MD, FIDSA is a physician in the Division of Infectious Diseases at Tufts Medical Center. She has been the physician head of the Antimicrobial Stewardship program there since 2005 and is also the Associate Hospital Epidemiologist.
Kirthana Beaulac, PharmD, BCPS is the pharmacist head of the Antimicrobial Stewardship program at Tufts Medical Center, as well as the Infectious Diseases Pharmacist for the institution.
|Infection Control: Surveillance and Monitoring|
|Introduction to Antimicrobial Stewardship in Long Term Care: What is Antimicrobial Stewardship and Why is it Important?|
|Antimicrobial Stewardship: Strategies for Implementation|
|Session 4 – April 3||Infection Control: Prevention|
|Session 5 – May 8||Approach to the Patient with Suspected UTI|
|Session 6 – June 12||Infection Control: Management (Case Scenarios)|
|Session 7 – July 10||Antibiotic Selection, De-Escalation, and Duration|
|Session 8 – August 14||How to Get an A on Your Report Card: Prevention and Management of C. difficile and Other Healthcare Associated Infections|
|Session 9 – September 11||Measure Your Success: Monitoring and Tracking Data|